BRCA2 and neoplasm: Notably, two patients (IDs 13 and 118) harbored tumor BRCA2 pathogenic variants at low VAF, alongside with pathogenic alterations in mismatch repair (MMR) genes, and both were MSI-high on subsequent analysis.